Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have changed the treatment pattern of advanced and metastatic NSCLC. A series of ICI based therapies have emerged in the first-line treatment field, but the comparative efficacy was unclear. METHOD: We searched multiple databases and abstracts of major...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Wu, Sijia, Fang, Weiwei, Li, Hongkai, Su, Lili, Qi, Guiye, Li, Huaichen, Liu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112813/
https://www.ncbi.nlm.nih.gov/pubmed/37071610
http://dx.doi.org/10.1371/journal.pone.0283719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112813/
https://www.ncbi.nlm.nih.gov/pubmed/37071610
http://dx.doi.org/10.1371/journal.pone.0283719

Ejemplares similares